140 related articles for article (PubMed ID: 28238185)
1. Can signal peptide-CUB-EGF domain-containing protein (SCUBE) levels be a marker of angiogenesis in patients with psoriasis?
Capkin AA; Demir S; Mentese A; Bulut Ç; Ayar A
Arch Dermatol Res; 2017 Apr; 309(3):203-207. PubMed ID: 28238185
[TBL] [Abstract][Full Text] [Related]
2. Is SCUBE 1 a new biomarker for gastric cancer?
Mentese A; Fidan E; Sumer AU; Karahan SC; Sonmez M; Altay DU; Kavgaci H; Alver A
Cancer Biomark; 2012; 11(5):191-5. PubMed ID: 23220851
[TBL] [Abstract][Full Text] [Related]
3. The relationship of serum SCUBE-1, -2 and -3 levels with clinical findings and ultrasonographic skin thickness in systemic sclerosis patients.
Gündüz İ; Batmaz İ; Bozan T; Ekinci A; Cevik R
Int J Rheum Dis; 2020 Apr; 23(4):526-531. PubMed ID: 31991528
[TBL] [Abstract][Full Text] [Related]
4. Novel inflammatory markers in psoriasis vulgaris: vaspin, vascular adhesion protein-1 (VAP-1), and YKL-40.
Ataseven A; Kesli R
G Ital Dermatol Venereol; 2016 Jun; 151(3):244-50. PubMed ID: 25279492
[TBL] [Abstract][Full Text] [Related]
5. Could SCUBE-1 be a marker for subclinical atherosclerosis other than carotid artery intima-media thickness in patients with psoriasis?
Ayvaz Çelik HH; Kuyumcu MS; Şirin FB; Cirit M; Korkmaz S; Erturan İ; Çelik S; Yıldırım M
An Bras Dermatol; 2023; 98(5):595-601. PubMed ID: 37198010
[TBL] [Abstract][Full Text] [Related]
6. Serum vascular endothelial growth factor, transforming growth factor β1, and nitric oxide levels in patients with psoriasis vulgaris: their correlation to disease severity.
Meki AR; Al-Shobaili H
J Clin Lab Anal; 2014 Nov; 28(6):496-501. PubMed ID: 24659464
[TBL] [Abstract][Full Text] [Related]
7. Effect of psoriasis therapy on VEGF and its soluble receptors serum concentrations.
Flisiak I; Zaniewski P; Rogalska-Taranta M; Chodynicka B
J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):302-7. PubMed ID: 21418334
[TBL] [Abstract][Full Text] [Related]
8. The Multifaceted Role of Signal Peptide-CUB-EGF Domain-Containing Protein (SCUBE) in Cancer.
Kumar S; Prajapati KS; Gupta S
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142489
[TBL] [Abstract][Full Text] [Related]
9. Zebrafish Scube1 and Scube2 cooperate in promoting Vegfa signalling during embryonic vascularization.
Tsao KC; Lin YC; Chen YT; Lai SL; Yang RB
Cardiovasc Res; 2022 Mar; 118(4):1074-1087. PubMed ID: 33788916
[TBL] [Abstract][Full Text] [Related]
10. Serum SCUBE-1 levels in patients with diabetic retinopathy.
Icel E; Icel A; Mertoglu C; Tasli NG; Karakurt Y; Ucak T; Gunay M
Int Ophthalmol; 2020 Apr; 40(4):859-865. PubMed ID: 31792853
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor in psoriasis: an indicator of disease severity and control.
Nofal A; Al-Makhzangy I; Attwa E; Nassar A; Abdalmoati A
J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):803-6. PubMed ID: 19309427
[TBL] [Abstract][Full Text] [Related]
12. Correlation between vascular endothelial growth factor and subclinical atherosclerosis in patients with psoriasis.
Shahidi-Dadras M; Haghighatkhah HR; Abdollahimajd F; Younespour S; Partovi Kia M; Zargari O
Int J Dermatol; 2016 Jan; 55(1):52-9. PubMed ID: 26135969
[TBL] [Abstract][Full Text] [Related]
13. The value of signal peptide-CUB-EGF domain-containing protein 1 and oxidative stress parameters in the diagnosis of acute mesenteric ischemia.
Turkmen S; Mentese S; Mentese A; Sumer AU; Saglam K; Yulug E; Turedi S; Gunduz A
Acad Emerg Med; 2013 Mar; 20(3):257-64. PubMed ID: 23517257
[TBL] [Abstract][Full Text] [Related]
14. Elevated plasma levels of vascular endothelial growth factor and plasminogen activator inhibitor-1 decrease during improvement of psoriasis.
Nielsen HJ; Christensen IJ; Svendsen MN; Hansen U; Werther K; Brünner N; Petersen LJ; Kristensen JK
Inflamm Res; 2002 Nov; 51(11):563-7. PubMed ID: 12540021
[TBL] [Abstract][Full Text] [Related]
15. Angiogenic activity in patients with psoriasis is significantly decreased by Goeckerman's therapy.
Andrys C; Borska L; Pohl D; Fiala Z; Hamakova K; Krejsek J
Arch Dermatol Res; 2007 Mar; 298(10):479-83. PubMed ID: 17221216
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of SCUBE-1 levels as a placental dysfunction marker at gestational diabetes mellitus.
Bayoglu Tekin Y; Baki Erin K; Yilmaz A
Gynecol Endocrinol; 2020 May; 36(5):417-420. PubMed ID: 31668102
[No Abstract] [Full Text] [Related]
17. Effect of psoriasis activity on epidermal growth factor (EGF) and the concentration of soluble EGF receptor in serum and plaque scales.
Flisiak I; Szterling-Jaworowska M; Baran A; Rogalska-Taranta M
Clin Exp Dermatol; 2014 Jun; 39(4):461-7. PubMed ID: 24825137
[TBL] [Abstract][Full Text] [Related]
18. Can signal peptide-CUB-EGF domain-containing protein 1 (SCUBE-1) be used as an indicator of endothelial dysfunction in acromegaly patients?
Tufekci D; Nuhoglu I; Ayan SS; Gunay YE; Coskun H; Bilginer MC; Ucuncu O; Kocak M; Yaman SO; Karahan SC
Endocrine; 2023 Oct; 82(1):152-160. PubMed ID: 37450216
[TBL] [Abstract][Full Text] [Related]
19. Notch-1 mediates endothelial cell activation and invasion in psoriasis.
Rooney P; Connolly M; Gao W; McCormick J; Biniecka M; Sullivan O; Kirby B; Sweeney C; Molloy E; Markham T; Fearon U; Veale DJ
Exp Dermatol; 2014 Feb; 23(2):113-8. PubMed ID: 24330353
[TBL] [Abstract][Full Text] [Related]
20. Serum interleukin-22 and vascular endothelial growth factor serve as sensitive biomarkers but not as predictors of therapeutic response to biologics in patients with psoriasis.
Shimauchi T; Hirakawa S; Suzuki T; Yasuma A; Majima Y; Tatsuno K; Yagi H; Ito T; Tokura Y
J Dermatol; 2013 Oct; 40(10):805-12. PubMed ID: 23915382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
